Advanced colorectal cancer: Anti-interleukin-1 alpha antibody MABp1 improves outcomes significantly over placebo

Posted by on July 2, 2016 6:44 pm
Categories: health

A novel anti-interleukin 1-alpha antibody has shown a significant impact on symptoms, and a high level of safety and tolerability in patients with advanced colorectal cancer, according to phase III data.

Leave a Reply

Your email address will not be published. Required fields are marked *